​Scandinavian Biopharma enters into Agreement with USAMRAA to facilitate the development of the oral vaccine ETVAX® against travellers’ diarrhoea

Scandinavian Biopharma (SBH) has entered into an Agreement with the United States Army Medical Research Acquisition Activity (USAMRAA) to support the production and development of the ETEC-vaccine, with the long-term goal of preventing bacterial diarrhoea in war fighters.
Läs mer